Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes.
Lee YJ, Park SW, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Lee WS, Lee SM, Joo YD, Kim H, Lee HS, Kim YS, Cho YY, Moon JH, Sohn SK. Lee YJ, et al. Among authors: lee hs, lee sm, lee ws, lee ih. Ann Hematol. 2016 Oct;95(11):1795-804. doi: 10.1007/s00277-016-2759-y. Epub 2016 Aug 17. Ann Hematol. 2016. PMID: 27530461
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome.
Sohn SK, Moon JH, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Park SW, Lee WS, Lee SM, Kim H, Lee HS, Kim YS, Cho YY, Bae SH, Lee JH, Kim SH, Song IC, Kwon JH, Lee YJ. Sohn SK, et al. Among authors: lee hs, lee sm, lee ws, lee ih, lee jh, lee yj. Korean J Intern Med. 2018 Nov;33(6):1194-1202. doi: 10.3904/kjim.2016.426. Epub 2017 Dec 15. Korean J Intern Med. 2018. PMID: 29232940 Free PMC article.
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.
Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA. Lee IH, et al. Among authors: lee kh, lee sa, lee jl. Korean J Intern Med. 2020 Jan;35(1):185-193. doi: 10.3904/kjim.2018.064. Epub 2018 Oct 12. Korean J Intern Med. 2020. PMID: 30301310 Free PMC article.
Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma.
Kim IH, Lee IH, Lee JE, Hong SH, Kim TJ, Lee KY, Kim YK, Kim SJ, Sung SW, Park JK, Yoo IR, Kim YS, Kim JO, Kang JH. Kim IH, et al. Among authors: lee je, lee ih, lee ky. Ann Surg Oncol. 2017 Mar;24(3):770-777. doi: 10.1245/s10434-016-5599-z. Epub 2016 Sep 30. Ann Surg Oncol. 2017. PMID: 27696172
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH, Lee IH, Lee JE, Hong SH, Kim TJ, Lee KY, Kim YK, Kim SJ, Sung SW, Park JK, Yoo IR, Kim YS, Kim JO, Kang JH. Kim IH, et al. Among authors: lee je, lee ih, lee ky. Clin Lung Cancer. 2016 Sep;17(5):e31-e43. doi: 10.1016/j.cllc.2016.01.005. Epub 2016 Feb 2. Clin Lung Cancer. 2016. PMID: 26992846
1,195 results